Envista Holdings (NVST)

NYSE Health Care Health Care Supplies S&P MidCap 400
$25.17
+0.21 (+0.84%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 04)
$0.40 vs $0.35 est.
Surprise +14.3%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 04, 2026Sep/2026$0.35$0.40+14.3%

Our record of NVST's reports since we began tracking; it grows each quarter.

Latest results, in brief

All NVST 8-K briefs →
Nov 4, 4:14 PM ET

Envista raises 2026 EPS guidance as Q3 adjusted EPS rises 25% to $0.40

Positive earnings 2.027.01

Envista reported third-quarter 2026 sales of $691.5 million, up 3.2% from a year earlier, with core sales growth of 2.7%. GAAP diluted EPS was $3.11, compared with a loss of $0.18 a year earlier, but that result includes a non-cash $428 million foreign currency translation gain, while adjusted diluted EPS rose to $0.40 from $0.32. The company raised its full-year 2026 adjusted diluted EPS guidance to $1.54 to $1.58 from $1.50 to $1.55.

  • Q3 sales $691.5 million vs. $669.9 million a year earlier; core sales growth 2.7%
  • GAAP diluted EPS $3.11 includes a $428 million non-cash currency translation gain ($2.62 per diluted share before tax)
  • Adjusted EBITDA $105.8 million, up from $97.1 million; adjusted EBITDA margin 15.3%
  • Updated 2026 guidance: adjusted diluted EPS $1.54 to $1.58 (prior $1.50 to $1.55); adjusted EBITDA growth 12.5% to 14% (prior 11% to 14%)
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Oct 2026$691.50M+3.2% $3.11— $508.30M73.5%
Jul 2026$730.50M+7.1% $0.33+106.2% $53.70M7.4%
Apr 2026$705.50M+14.4% $0.23+130.0% $38.70M5.5%
Dec 2025$750.60M+15.0% $0.20+1900.0% $32.90M4.4%
Sep 2025$669.90M+11.5% $-0.18-460.0% -$30.30M-4.5%
Jun 2025$682.10M+7.7% $0.16— $26.40M3.9%
Mar 2025$616.90M-1.1% $0.10-28.6% $18.00M2.9%
Dec 2024$652.90M+1.1% $0.01— $1.20M0.2%

From Envista Holdings's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$2.72B+8.3% $0.28—1.7%
FY2024$2.51B-2.2% $-6.50—-44.6%
FY2023$2.57B-0.1% $-0.60-143.8%-3.9%
FY2022$2.57B+2.4% $1.37-28.6%9.5%
FY2021$2.51B+30.1% $1.92+860.0%13.6%

Frequently asked questions

When is Envista's next earnings date?

Envista has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Envista earn last quarter?

For the quarter ended Oct 2026, Envista reported diluted EPS of $3.11 on revenue of $691.50M (+3.2%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.